Literature DB >> 12741131

Bisalkaloid derivatives of dicarboxylic acids on the basis of lupinine, anabasine, and cytisine as reversible cholinesterase inhibitors.

E V Rozengart1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12741131     DOI： 10.1023/a:1022560630021

Source DB:  PubMed          Journal:  Dokl Biochem Biophys        ISSN： 1607-6729            Impact factor:   0.788


× No keyword cloud information.
  5 in total

1.  A new and rapid colorimetric determination of acetylcholinesterase activity.

Authors:  G L ELLMAN; K D COURTNEY; V ANDRES; R M FEATHER-STONE
Journal:  Biochem Pharmacol       Date:  1961-07       Impact factor: 5.858

2.  [The role of steric characteristics of the gangliolytic molecule in its interaction with cholinoreceptor].

Authors:  V E Gmiro; N Ia Lukomskaia; S E Serdiuk
Journal:  Dokl Akad Nauk SSSR       Date:  1987

3.  [Interaction of frog brain cholinesterase with some reversible ammonium inhibitors].

Authors:  A P Brestkin; T N Viniar; E V Rozengart
Journal:  Biokhimiia       Date:  1981-06

4.  [Kinetics of enzymatic hydrolysis of quaternary aminoalkyl esters of aromatic mono- and dicarboxylic acids by butyrylcholinesterase from horse serum].

Authors:  R I Volkova; E N Dmitrieva
Journal:  Biokhimiia       Date:  1976-02

5.  [Interaction between various cholinesterases and reversible inhibitors of polymethylene-bis-(trimethylammonium) diiodide series].

Authors:  A P Brestkin; T N Viniar; E V Rozengart
Journal:  Ukr Biokhim Zh (1978)       Date:  1983 Jan-Feb
  5 in total
  2 in total

1.  New substrates and reversible inhibitors of cholinesterases based on esters and thioesters of noncholine cyclic ammonium alcohols.

Authors:  E V Rozengart; N E Basova
Journal:  Dokl Biochem Biophys       Date:  2008 Jan-Feb       Impact factor: 0.788

2.  Cholinesterase hydrolysis of substituted lupinine benzoates.

Authors:  N E Basova; E V Rozengart; A A Suvorov
Journal:  Dokl Biochem Biophys       Date:  2008 Mar-Apr       Impact factor: 0.834
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.